Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$11.74−1.01 (-7.92%)
Close on Nov 17, 2026Market cap $79.70MP/E –Yield –
Eloxx Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Eloxx Pharmaceuticals's total assets was $63.39M at Jun 30, 2026. For fiscal 2025 it was $5.27M, up 77.1% from the year before. Over ten years it grew -16.8% a year on average. The highest annual figure on record is $58.95M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.27M | +77.1% |
| FY2024 | Dec 31, 2024 | $2.98M | +73.8% |
| FY2023 | Dec 31, 2023 | $1.71M | -91.9% |
| FY2022 | Dec 31, 2022 | $21.12M | -53.2% |
| FY2021 | Dec 31, 2021 | $45.14M | +70.5% |
| FY2020 | Dec 31, 2020 | $26.48M | -55.1% |
| FY2019 | Dec 31, 2019 | $58.95M | +16.2% |
| FY2018 | Dec 31, 2018 | $50.72M | +449.7% |
| FY2016 | Jun 30, 2016 | $9.23M | -52.8% |
| FY2015 | Jun 30, 2015 | $19.55M | -41.4% |
| FY2014 | Jun 30, 2014 | $33.33M | +369.7% |
| FY2013 | Jun 30, 2013 | $7.10M | +2.1% |
| FY2012 | Jun 30, 2012 | $6.95M | -19.1% |
| FY2011 | Jun 30, 2011 | $8.60M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $63.39M | +3602.6% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $8.50M | +40.7% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $5.27M | -12.1% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $2.98M | -58.7% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $1.71M | -91.9% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $6.04M | -77.5% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $5.99M | -81.8% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $7.20M | -83.5% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $21.12M | -53.2% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $26.88M | -51.5% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $32.94M | -45.7% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $43.62M | +114.2% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $45.14M | +70.5% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $55.38M | +68.1% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $60.61M | +51.8% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $20.37M | -56.7% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $26.48M | -55.1% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $32.94M | -51.6% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $39.92M | -49.5% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $47.04M | -17.3% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $58.95M | +16.2% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $68.06M | +20.4% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $79.04M | +23.0% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $56.89M | +197.0% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $50.72M | +449.7% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $56.54M | +435.4% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $64.27M | +310.8% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $19.16M | -1.5% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $9.23M | -52.8% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $10.56M | -37.6% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $15.64M | -15.7% |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $19.44M | -30.9% |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $19.55M | -41.4% |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | $16.92M | +54.4% |
| Q2 FY2015CQ4 2014 | Dec 31, 2014 | $18.55M | – |
| Q1 FY2015CQ3 2014 | Sep 30, 2014 | $28.14M | – |
| Q4 FY2014CQ2 2014 | Jun 30, 2014 | $33.33M | – |
| Q3 FY2014CQ1 2014 | Mar 31, 2014 | $10.96M | – |
See a number that looks wrong?